What is the address of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES?

The registered office of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is located at Mariannestraat 16 box 7, 1180 Ukkel.

Is EUROPEAN CENTER OF CARDIOVASCULAR DESEASES still active?

Yes. According to the CBE (29 September 2026) EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is active, legal situation “Normale toestand”, started on 22 September 2005.

Is EUROPEAN CENTER OF CARDIOVASCULAR DESEASES registered on Peppol?

Yes, EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is registered on the Peppol network with ID 0208:0876207730.

What is the enterprise number of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES?

The enterprise number of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is BE0876207730.

When was EUROPEAN CENTER OF CARDIOVASCULAR DESEASES founded?

EUROPEAN CENTER OF CARDIOVASCULAR DESEASES was founded on 22 September 2005.

Who are the directors of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES?

According to the 2025 annual accounts, the directors of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES are: Denis Muck.

Is EUROPEAN CENTER OF CARDIOVASCULAR DESEASES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 September 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did EUROPEAN CENTER OF CARDIOVASCULAR DESEASES make in 2025?

EUROPEAN CENTER OF CARDIOVASCULAR DESEASES posted a profit after taxes of € 22,681 in financial year 2025.

What is the revenue of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES?

As a small company, EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -110.

EUROPEAN CENTER OF CARDIOVASCULAR DESEASES (Private Limited)

Dossier EUROPEAN CENTER OF CARDIOVASCULAR DESEASES, printed on 29 September 2026 from databakkes.be/en/0876207730/european-center-of-cardiovascular-deseases. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EUROPEAN CENTER OF CARDIOVASCULAR DESEASES from Ukkel, company number BE0876207730, closed financial year 2025 with a result of € 22,681 after tax. For that financial year EUROPEAN CENTER OF CARDIOVASCULAR DESEASES recorded a gross margin of € -110 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 19,743 to € 22,681. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 1.3 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,681

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,822

▲ 254% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.3 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 520

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 59,007 Gross margin 2022: € 59,007 First fiscal year in the series	€ 17,991 Gross margin 2023: € 17,991 ▼ 70% vs 2022 (€ 59,007) Unfavourable step	€ -2,988 Gross margin 2024: € -2,988 ▼ € 20,979 vs 2023 (€ 17,991) Unfavourable step	€ -110 Gross margin 2025: € -110 ▲ € 2,878 vs 2024 (€ -2,988) Favourable step	▲ € 2,878
Profit after taxes	€ 61,803 Profit after taxes 2022: € 61,803 First fiscal year in the series	€ 35,448 Profit after taxes 2023: € 35,448 ▼ 43% vs 2022 (€ 61,803) Unfavourable step	€ 19,743 Profit after taxes 2024: € 19,743 ▼ 44% vs 2023 (€ 35,448) Unfavourable step	€ 22,681 Profit after taxes 2025: € 22,681 ▲ 15% vs 2024 (€ 19,743) Favourable step	▲ 15%
Equity	€ 1,239,214 Equity 2022: € 1,239,214 First fiscal year in the series	€ 1,274,662 Equity 2023: € 1,274,662 ▲ 3% vs 2022 (€ 1,239,214) Favourable step	€ 1,294,405 Equity 2024: € 1,294,405 ▲ 2% vs 2023 (€ 1,274,662) Favourable step	€ 1,317,086 Equity 2025: € 1,317,086 ▲ 2% vs 2024 (€ 1,294,405) Favourable step	▲ 2%
Total debts	€ 31,015 Total debts 2022: € 31,015 First fiscal year in the series	€ 42,221 Total debts 2023: € 42,221 ▲ 36% vs 2022 (€ 31,015) Unfavourable step	€ 508 Total debts 2024: € 508 ▼ 99% vs 2023 (€ 42,221) Favourable step	€ 520 Total debts 2025: € 520 ▲ 2% vs 2024 (€ 508) Unfavourable step	▲ 2%
Cash	€ 44,868 Cash 2022: € 44,868 First fiscal year in the series	€ 47,982 Cash 2023: € 47,982 ▲ 7% vs 2022 (€ 44,868) Favourable step	€ 515 Cash 2024: € 515 ▼ 99% vs 2023 (€ 47,982) Unfavourable step	€ 1,822 Cash 2025: € 1,822 ▲ 254% vs 2024 (€ 515) Favourable step	▲ 254%
Retained profit	€ 1,233,014 Retained profit 2022: € 1,233,014 First fiscal year in the series	€ 1,268,462 Retained profit 2023: € 1,268,462 ▲ 3% vs 2022 (€ 1,233,014) Favourable step	€ 1,288,205 Retained profit 2024: € 1,288,205 ▲ 2% vs 2023 (€ 1,268,462) Favourable step	€ 1,310,886 Retained profit 2025: € 1,310,886 ▲ 2% vs 2024 (€ 1,288,205) Favourable step	▲ 2%
Balance sheet total	€ 1,270,229 Balance sheet total 2022: € 1,270,229 First fiscal year in the series	€ 1,316,883 Balance sheet total 2023: € 1,316,883 ▲ 4% vs 2022 (€ 1,270,229) Unchanged	€ 1,294,913 Balance sheet total 2024: € 1,294,913 ▼ 2% vs 2023 (€ 1,316,883) Unchanged	€ 1,317,606 Balance sheet total 2025: € 1,317,606 ▲ 2% vs 2024 (€ 1,294,913) Unchanged	▲ 2%

Key figures of EUROPEAN CENTER OF CARDIOVASCULAR DESEASES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EUROPEAN CENTER OF CARDIOVASCULAR DESEASES?

What happened at EUROPEAN CENTER OF CARDIOVASCULAR DESEASES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 22,681 (▲ 15% vs 2024). filed late Source: NBB ↗
Sep 22, 2005 New establishment in Ukkel. KBO
Sep 22, 2005 Start of the company according to the CBE. KBO

In short

From € 61,803 profit in 2022 to € 22,681 profit in 2025.

Paid € 53,827 in corporate taxes since 2022.

Best year ever: 2022, with € 61,803 profit.

Original PDFs at the National Bank ↗

A new publication or filing at EUROPEAN CENTER OF CARDIOVASCULAR DESEASES? We notify you, reason included.

Follow EUROPEAN CENTER OF CARDIOVASCULAR DESEASES

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Denis Muck

EUROPEAN CENTER OF CARDIOVASCULAR DESEASES

Behind EUROPEAN CENTER OF CARDIOVASCULAR DESEASES is Denis Muck.

See the full network in the app

Directors

According to the 2025 annual accounts

Denis Muck

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Mariannestraat 16 box 7

1180 Ukkel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

INSTITUT DE RECHERCHE ET DE DEVELOPPEMENT EN ALICAMENTS

€ -67 gross margin · 2025

VETOPET

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0876.207.730
VAT number: BE 0876.207.730
Registered office: Mariannestraat 16 bus 7, 1180 Ukkel
Names & denominations: EUROPEAN CENTER OF CARDIOVASCULAR DESEASES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 September 2005
Peppol: Active · Active since 8 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗